Purpose and Appropriate Sample TypeThe common usage of animal models in a variety of preclinical studies is supported by appropriate species‐specific antibodies to be utilized in immunohistochemistry (IHC), western blotting, and flow cytometry (FC) assays. Other than the technical advantages (sophisticated surgical manipulations due to their size), modest cost (relative to larger animals), and the standardized results, the similarities in metabolic activity and physiology of neurological disorders to humans make rats appropriate for neurological disease or disorders models . However, rat‐based assays are not as comprehensive or standardized as mouse or human based assays are, partially because there is a shortage in rat‐specific antibodies. Rat‐specific antibodies are now becoming commercially available, which allows us to set standardize criteria for rat origin cells of interest. As our research focus is in neurotherapy, we are interested specifically in microglial cells, which are the innate immune cells in the brain and spinal cord . Microglial cells play a critical role in traumatic brain injuries (TBI) and spinal cord injuries (SCI), and their presence, activation, and effect are highly investigated in those models . Microglial characterization via FC would save many hours of work as a substitute for IHC analysis, yield unbiased statistics,
Cytometry – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud